East Rocky Health Sciences Fund

Platinum Investment Management Limited (“PIML”) (ABN 25 063 565 006), AFSL 221935, is the Responsible Entity for the East Rocky Health Sciences Fund ARSN 107 023 530.

This page has been prepared by East Rocky Asset Management LLC (an Authorised Representative (no. 1323380) of L1 Capital Pty Ltd ABN 21 125 378 145 Australian Financial Services Licence number 314302) and East Rocky Biotech Asset Management Pty Ltd (an Authorised Representative (no. 1323257) of L1 Capital (“East Rocky”), to provide you with general information only. In preparing it, we did not take into account the investment objectives, financial situation or particular needs of any particular person. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Neither East Rocky, PIML nor any of their related parties, their employees or directors, provide any warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it. All performance numbers are quoted after fees. Past performance should not be taken as an indicator of future performance. You should obtain a copy of the Product Disclosure Statement before making a decision about whether to invest in this product.

For more information:

• East Rocky Health Sciences Fund Product Disclosure Statement
• East Rocky Health Sciences Fund TMD

Copyright

Copyright in the information on this page is owned by East Rocky. You may use this information in this publication for your own personal use, but you must not (without East Rocky’s consent) alter, reproduce or distribute any part of this publication, transmit it to any other person or incorporate the information into any other document.